Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 61, Issue 5, Pages 1615-1626
Publisher
Wiley
Online
2015-01-08
DOI
10.1002/hep.27686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth
- (2014) T Chen et al. CANCER GENE THERAPY
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human CD14+CTLA-4+regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma
- (2013) Yanmei Han et al. HEPATOLOGY
- Temporal regulation of EGF signalling networks by the scaffold protein Shc1
- (2013) Yong Zheng et al. NATURE
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- The endocannabinoid signaling system in cancer
- (2013) Simona Pisanti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Novel functions of FoxM1: from molecular mechanisms to cancer therapy
- (2013) Mónica Alvarez-Fernández et al. Frontiers in Oncology
- CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
- (2012) Q. Gao et al. CANCER RESEARCH
- Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2
- (2012) Chi-Chuan Lin et al. CELL
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
- (2012) Jie Liu et al. GASTROENTEROLOGY
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
- (2011) D Vara et al. CELL DEATH AND DIFFERENTIATION
- Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver
- (2011) B. Mukhopadhyay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γ
- (2010) Bani Mukhopadhyay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mouse Models of Hepatocellular Carcinoma
- (2010) Nelson Fausto et al. SEMINARS IN LIVER DISEASE
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
- The endocannabinoid system in cancer—Potential therapeutic target?
- (2008) Jenny Flygare et al. SEMINARS IN CANCER BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started